JP2023029957A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023029957A5 JP2023029957A5 JP2022193738A JP2022193738A JP2023029957A5 JP 2023029957 A5 JP2023029957 A5 JP 2023029957A5 JP 2022193738 A JP2022193738 A JP 2022193738A JP 2022193738 A JP2022193738 A JP 2022193738A JP 2023029957 A5 JP2023029957 A5 JP 2023029957A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- polypeptide
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662428492P | 2016-11-30 | 2016-11-30 | |
| US62/428,492 | 2016-11-30 | ||
| US201762553313P | 2017-09-01 | 2017-09-01 | |
| US62/553,313 | 2017-09-01 | ||
| JP2019529240A JP7649624B2 (ja) | 2016-11-30 | 2017-11-30 | 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生 |
| PCT/US2017/064081 WO2018102616A1 (en) | 2016-11-30 | 2017-11-30 | Fracture targeted bone regeneration through parathyroid hormone receptor stimulation |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019529240A Division JP7649624B2 (ja) | 2016-11-30 | 2017-11-30 | 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023029957A JP2023029957A (ja) | 2023-03-07 |
| JP2023029957A5 true JP2023029957A5 (enExample) | 2023-07-28 |
Family
ID=62241919
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019529240A Active JP7649624B2 (ja) | 2016-11-30 | 2017-11-30 | 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生 |
| JP2022193738A Pending JP2023029957A (ja) | 2016-11-30 | 2022-12-02 | 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019529240A Active JP7649624B2 (ja) | 2016-11-30 | 2017-11-30 | 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20200317745A1 (enExample) |
| EP (1) | EP3548012A4 (enExample) |
| JP (2) | JP7649624B2 (enExample) |
| CN (1) | CN110114065A (enExample) |
| AU (1) | AU2017367699B2 (enExample) |
| BR (1) | BR112019011070A2 (enExample) |
| CA (1) | CA3045458A1 (enExample) |
| IL (1) | IL266977B2 (enExample) |
| MX (1) | MX2019006189A (enExample) |
| WO (1) | WO2018102616A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3045458A1 (en) * | 2016-11-30 | 2018-06-07 | Purdue Research Foundation | Fracture targeted bone regeneration through parathyroid hormone receptor stimulation |
| EP3796941A4 (en) * | 2018-05-30 | 2022-12-28 | Purdue Research Foundation | Targeting anabolic drugs for accelerated fracture repair |
| CN110551201B (zh) * | 2019-08-26 | 2020-04-28 | 杭州彗搏科技有限公司 | 一种新型骨形成蛋白2来源的环肽、制备方法及其应用 |
| CN114364327A (zh) * | 2019-09-12 | 2022-04-15 | 雷迪厄斯健康公司 | 用阿巴帕肽改善脊柱融合的方法 |
| CN112646042A (zh) * | 2019-10-10 | 2021-04-13 | 陕西麦科奥特科技有限公司 | 活性多肽化合物 |
| WO2022051555A2 (en) * | 2020-09-03 | 2022-03-10 | Rampart Bioscience, Inc. | Soluble alkaline phosphatase constructs and expression vectors including a polynucleotide encoding for soluble alkaline phosphatase constructs |
| WO2022093373A1 (en) * | 2020-10-26 | 2022-05-05 | Purdue Research Foundation | Compounds,compositions and methods of use to treat bone fractures |
| JP2023547889A (ja) * | 2020-10-26 | 2023-11-14 | パーデュー・リサーチ・ファウンデーション | 脊椎融合を治療するための化合物、組成物、および使用の方法 |
| AU2022205801A1 (en) * | 2021-01-05 | 2023-07-13 | Radius Health, Inc. | Treatment of long bone fractures with abaloparatide |
| WO2023136866A1 (en) * | 2022-01-14 | 2023-07-20 | Novosteo Llc | Bone targeted treatment in osteogenesis imperfecta |
| WO2024246840A1 (en) * | 2023-06-01 | 2024-12-05 | Radius Health, Inc. | Methods for identification and quantitation of abaloparatide and related peptide impurities |
| WO2025019691A1 (en) * | 2023-07-19 | 2025-01-23 | Zymeron Corporation | Drug conjugates for bone marrow protection |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU9103791A (en) * | 1990-12-21 | 1992-07-22 | Allelix Biopharmaceuticals Inc. | Oxidation resistant variants of parathyroid hormone |
| WO1995002610A1 (en) * | 1993-07-13 | 1995-01-26 | Syntex (U.S.A.) Inc. | Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| EP1950224A3 (en) * | 1998-03-09 | 2008-12-17 | Zealand Pharma A/S | Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| US7057012B1 (en) * | 1998-12-31 | 2006-06-06 | The General Hospital Corporation | PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
| JP2000327583A (ja) | 1999-05-17 | 2000-11-28 | Medei Sci Puraningu:Kk | 骨指向性ホルモン誘導体 |
| WO2004062588A2 (en) * | 2003-01-06 | 2004-07-29 | University Of Utah | Water-soluble polymeric bone-targeting drug delivery system |
| HUE055861T2 (hu) | 2004-04-21 | 2021-12-28 | Alexion Pharma Inc | Csontbejuttató konjugátumok és azok alkalmazási módszere fehérjék csonthoz kötéséhez |
| US7863238B2 (en) | 2004-06-10 | 2011-01-04 | Saint Louis University | Proteins with an attached short peptide of acidic amino acids |
| US20110046059A1 (en) * | 2005-09-06 | 2011-02-24 | Zelos Therapeutics, Inc. | Pharmaceutically acceptable formulations/compositions for peptidyl drugs |
| US7803770B2 (en) * | 2006-10-03 | 2010-09-28 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
| JP5375611B2 (ja) | 2006-10-03 | 2013-12-25 | ラジウス ヘルス，インコーポレイテッド | 骨同化作用を有するタンパク質のための薬物送達方法 |
| DK2155874T3 (en) * | 2007-04-09 | 2016-08-01 | Univ Arkansas | FUSION PROTEIN OF COLLAGE BINDING DOMAIN AND parathyroid hormone |
| PL2158319T4 (pl) * | 2007-05-11 | 2016-04-29 | Alexion Pharma Inc | Fosfataza alkaliczna kierowana do kości, zestawy i zastosowanie |
| WO2009141823A2 (en) * | 2008-05-22 | 2009-11-26 | Ramot At Tel Aviv University Ltd. | Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases |
| WO2012111852A1 (ja) * | 2011-02-17 | 2012-08-23 | 帝人ファーマ株式会社 | 椎体骨折治療剤及びその評価方法 |
| US20130006217A1 (en) * | 2011-04-22 | 2013-01-03 | Gary Hattersley | METHOD OF DRUG DELIVERY FOR PTH, PTHrP AND RELATED PEPTIDES |
| CN102824647B (zh) * | 2011-06-13 | 2014-07-23 | 香港中文大学 | 基于小核酸药物成骨治疗的骨靶向递送系统及其制备方法 |
| WO2014033540A2 (en) * | 2012-08-28 | 2014-03-06 | The Governors Of The University Of Alberta | Parathyroid hormone, insulin, and related peptides conjugated to bone targeting moieties and methods of making and using thereof |
| EP3016674A4 (en) | 2013-06-23 | 2017-03-15 | Wisconsin Alumni Research Foundation | Alpha-/beta-polypeptide analogs of parathyroid hormone (pth) and method of using same |
| EP4137147A3 (en) * | 2015-03-03 | 2023-04-05 | Radius Health, Inc. | Uses of abaloparatide in reducing fracture risk |
| WO2016196400A1 (en) * | 2015-05-29 | 2016-12-08 | Purdue Research Foundation | Bone fracture repair by targeting of agents that promote bone healing |
| CN106039316B (zh) * | 2016-05-03 | 2019-04-02 | 同济大学 | 一种基于多肽构建的成骨细胞靶向载体及其制备与应用 |
| CA3045458A1 (en) * | 2016-11-30 | 2018-06-07 | Purdue Research Foundation | Fracture targeted bone regeneration through parathyroid hormone receptor stimulation |
| WO2022093373A1 (en) * | 2020-10-26 | 2022-05-05 | Purdue Research Foundation | Compounds,compositions and methods of use to treat bone fractures |
-
2017
- 2017-11-30 CA CA3045458A patent/CA3045458A1/en active Pending
- 2017-11-30 JP JP2019529240A patent/JP7649624B2/ja active Active
- 2017-11-30 MX MX2019006189A patent/MX2019006189A/es unknown
- 2017-11-30 BR BR112019011070A patent/BR112019011070A2/pt active Search and Examination
- 2017-11-30 CN CN201780073942.4A patent/CN110114065A/zh active Pending
- 2017-11-30 US US16/464,164 patent/US20200317745A1/en not_active Abandoned
- 2017-11-30 EP EP17875427.1A patent/EP3548012A4/en active Pending
- 2017-11-30 AU AU2017367699A patent/AU2017367699B2/en active Active
- 2017-11-30 IL IL266977A patent/IL266977B2/en unknown
- 2017-11-30 WO PCT/US2017/064081 patent/WO2018102616A1/en not_active Ceased
-
2020
- 2020-03-31 US US16/836,366 patent/US10960054B2/en active Active
-
2021
- 2021-02-24 US US17/184,400 patent/US20210283227A1/en active Pending
-
2022
- 2022-12-02 JP JP2022193738A patent/JP2023029957A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023029957A5 (enExample) | ||
| JP2020500871A5 (enExample) | ||
| CN105934257B (zh) | 用于含氮和羟基的药物的生物可逆引入基团 | |
| JP7649624B2 (ja) | 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生 | |
| JP4142743B2 (ja) | 副甲状腺ホルモンに関連する新規ペプチド類似体 | |
| JP2013173763A (ja) | エリスロポエチンレセプターペプチドの処方および使用 | |
| JP2008512117A5 (enExample) | ||
| JP4541899B2 (ja) | ラクタム架橋を有する、コンホメーションが制限された副甲状腺ホルモン（ｐｔｈ）アナログ | |
| KR20010023795A (ko) | 피티에이치알피 유사체를 사용하는 골절 치료법 | |
| CZ100693A3 (en) | Non-peptidic antagonists of bembesin | |
| ES2207740T3 (es) | Analogo de la hormona paratiroide para el tratamiento de la osteoporosis. | |
| JPH11505109A (ja) | Ｏｂ蛋白の生物学的活性ペプチドフラグメント | |
| JP2013538564A (ja) | 抗ウイルス剤 | |
| JP2007528836A (ja) | α−ヘリックス安定化剤を用いる高次構造的に制約された副甲状腺ホルモン | |
| CN109153708A (zh) | 重组卵泡抑素-fc融合蛋白及其在治疗杜氏肌营养不良症中的应用 | |
| NL8901059A (nl) | Zuuradditiezouten van geamideerd taurine of glycine, werkwijzen voor hun bereiding en hun toepassing. | |
| Lühmann et al. | Biodistribution of site-specific PEGylated fibroblast growth factor-2 | |
| CN102405229A (zh) | 作为甲状旁腺激素(pth)受体激动剂的短链肽 | |
| US9556229B2 (en) | Modification of peptides using a bis(thioether)arylbridge approach | |
| JPH10502091A (ja) | ＰＴＨまたはＰＴＨｒＰアンタゴニスト | |
| JP2009507844A5 (enExample) | ||
| EP0656784A1 (en) | Parathyroid hormone fragments and analogs | |
| HUP9904049A2 (hu) | Növekedési hormon komponens és csont antireszorpciós hatóanyag együttes felhasználása a csontritkulás ciklikus(koherens) kezelésében | |
| JP5529014B2 (ja) | 部位特異的なペグ化をされた直鎖状のサケカルシトニン類似体 | |
| US20230173086A1 (en) | Peptide conjugates and therapeutic agents having improved pharmacological and pharmacokinetic properties |